Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Triple-dummy Trial to Compare the Efficacy of Otamixaban With Unfractionated Heparin + Eptifibatide, in Patients With Unstable Angina/Non ST Segment Elevation Myocardial Infarction Scheduled to Undergo an Early Invasive Strategy

NCT01076764 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01076764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01076764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Triple-dummy Trial to Compare the Efficacy of Otamixaban With Unfractionated Heparin + Eptifibatide, in Patients With Unstable Angina/Non ST Segment Elevation Myocardial Infarction Scheduled to Undergo an Early Invasive Strategy
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2010
Completion date
May 31, 2013
Enrollment
13,220 (actual)
Sites
607

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome